• Citer

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

par Eggermont, Alexander A.M.M.;Suciu, Stefan ;Santinami, M.;Testori, Alessandro;Kruit, Wim H;Marsden, Jeremy;Punt, Cornelis;Sales, François ;Gore, Martin;Mackie, Rona;Kusic, Zvonko;Dummer, Reinhard;Hauschild, Axel;Musat, E.;Spatz, Alain;Keilholz, Ulrich
Référence Lancet, 372, 9633, page (117-126)
Publication Publié, 2008

Article révisé par les pairs

• Détails
• Contenu

Titre:	Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial
Auteur:	Eggermont, Alexander A.M.M.; Suciu, Stefan; Santinami, M.; Testori, Alessandro; Kruit, Wim H; Marsden, Jeremy; Punt, Cornelis; Sales, François; Gore, Martin; Mackie, Rona; Kusic, Zvonko; Dummer, Reinhard; Hauschild, Axel; Musat, E.; Spatz, Alain; Keilholz, Ulrich
Informations sur la publication:	Lancet, 372, 9633, page (117-126)
Statut de publication:	Publié, 2008
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0140-6736
	info:doi/10.1016/S0140-6736(08)61033-8
	info:pii/S0140673608610338
	info:scp/46749103710